Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure

Salvatore Rosanio, Ernst R. Schwarz, Masood Ahmad, Praveen Jammula, Antonio Vitarelli, Barry F. Uretsky, Yochai Birnbaum, David L. Ware, Shaul Atar, Mohammad Saeed

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

This review aims to provide a synthesis of the published evidence regarding the rationale and clinical benefits of cardiac resynchronization therapy (CRT) with implantable atrial-synchronized biventricular pacing (BVP) devices in patients with moderate to advanced heart failure and intra- and interventricular conduction delays. In addition, it addresses clinical and technical issues that have yet to be resolved, such as the selection of the most suitable candidates for CRT; the usefulness of combining BVP with automatic defibrillation backup; the value of CRT in patients with atrial fibrillation; the importance of alternative sites of pacing, such as the atrial septum and the right ventricular (RV) outflow tract; the harmful effects of the long-standing practice of producing an iatrogenic left bundle branch block by conventional RV pacing in patients receiving standard permanent pacemakers; the question of precisely where on the left ventricle optimal pacing is achieved; and the potential applications of CRT in patients with pediatric or congenital heart disease. Considering how major advances have been achieved since the first clinical application of CRT in 1994, one can be optimistic about the future of the electrotherapeutic management of heart failure.

Original languageEnglish (US)
Pages (from-to)710-717
Number of pages8
JournalAmerican Journal of Cardiology
Volume96
Issue number5
DOIs
StatePublished - Sep 1 2005

Fingerprint

Cardiac Resynchronization Therapy
Heart Failure
Atrial Septum
Bundle-Branch Block
Atrial Fibrillation
Heart Ventricles
Heart Diseases
Pediatrics
Equipment and Supplies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure. / Rosanio, Salvatore; Schwarz, Ernst R.; Ahmad, Masood; Jammula, Praveen; Vitarelli, Antonio; Uretsky, Barry F.; Birnbaum, Yochai; Ware, David L.; Atar, Shaul; Saeed, Mohammad.

In: American Journal of Cardiology, Vol. 96, No. 5, 01.09.2005, p. 710-717.

Research output: Contribution to journalArticle

Rosanio, S, Schwarz, ER, Ahmad, M, Jammula, P, Vitarelli, A, Uretsky, BF, Birnbaum, Y, Ware, DL, Atar, S & Saeed, M 2005, 'Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure', American Journal of Cardiology, vol. 96, no. 5, pp. 710-717. https://doi.org/10.1016/j.amjcard.2005.04.050
Rosanio, Salvatore ; Schwarz, Ernst R. ; Ahmad, Masood ; Jammula, Praveen ; Vitarelli, Antonio ; Uretsky, Barry F. ; Birnbaum, Yochai ; Ware, David L. ; Atar, Shaul ; Saeed, Mohammad. / Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure. In: American Journal of Cardiology. 2005 ; Vol. 96, No. 5. pp. 710-717.
@article{871b83243cc54e1baed6911f9bca64e6,
title = "Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure",
abstract = "This review aims to provide a synthesis of the published evidence regarding the rationale and clinical benefits of cardiac resynchronization therapy (CRT) with implantable atrial-synchronized biventricular pacing (BVP) devices in patients with moderate to advanced heart failure and intra- and interventricular conduction delays. In addition, it addresses clinical and technical issues that have yet to be resolved, such as the selection of the most suitable candidates for CRT; the usefulness of combining BVP with automatic defibrillation backup; the value of CRT in patients with atrial fibrillation; the importance of alternative sites of pacing, such as the atrial septum and the right ventricular (RV) outflow tract; the harmful effects of the long-standing practice of producing an iatrogenic left bundle branch block by conventional RV pacing in patients receiving standard permanent pacemakers; the question of precisely where on the left ventricle optimal pacing is achieved; and the potential applications of CRT in patients with pediatric or congenital heart disease. Considering how major advances have been achieved since the first clinical application of CRT in 1994, one can be optimistic about the future of the electrotherapeutic management of heart failure.",
author = "Salvatore Rosanio and Schwarz, {Ernst R.} and Masood Ahmad and Praveen Jammula and Antonio Vitarelli and Uretsky, {Barry F.} and Yochai Birnbaum and Ware, {David L.} and Shaul Atar and Mohammad Saeed",
year = "2005",
month = "9",
day = "1",
doi = "10.1016/j.amjcard.2005.04.050",
language = "English (US)",
volume = "96",
pages = "710--717",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure

AU - Rosanio, Salvatore

AU - Schwarz, Ernst R.

AU - Ahmad, Masood

AU - Jammula, Praveen

AU - Vitarelli, Antonio

AU - Uretsky, Barry F.

AU - Birnbaum, Yochai

AU - Ware, David L.

AU - Atar, Shaul

AU - Saeed, Mohammad

PY - 2005/9/1

Y1 - 2005/9/1

N2 - This review aims to provide a synthesis of the published evidence regarding the rationale and clinical benefits of cardiac resynchronization therapy (CRT) with implantable atrial-synchronized biventricular pacing (BVP) devices in patients with moderate to advanced heart failure and intra- and interventricular conduction delays. In addition, it addresses clinical and technical issues that have yet to be resolved, such as the selection of the most suitable candidates for CRT; the usefulness of combining BVP with automatic defibrillation backup; the value of CRT in patients with atrial fibrillation; the importance of alternative sites of pacing, such as the atrial septum and the right ventricular (RV) outflow tract; the harmful effects of the long-standing practice of producing an iatrogenic left bundle branch block by conventional RV pacing in patients receiving standard permanent pacemakers; the question of precisely where on the left ventricle optimal pacing is achieved; and the potential applications of CRT in patients with pediatric or congenital heart disease. Considering how major advances have been achieved since the first clinical application of CRT in 1994, one can be optimistic about the future of the electrotherapeutic management of heart failure.

AB - This review aims to provide a synthesis of the published evidence regarding the rationale and clinical benefits of cardiac resynchronization therapy (CRT) with implantable atrial-synchronized biventricular pacing (BVP) devices in patients with moderate to advanced heart failure and intra- and interventricular conduction delays. In addition, it addresses clinical and technical issues that have yet to be resolved, such as the selection of the most suitable candidates for CRT; the usefulness of combining BVP with automatic defibrillation backup; the value of CRT in patients with atrial fibrillation; the importance of alternative sites of pacing, such as the atrial septum and the right ventricular (RV) outflow tract; the harmful effects of the long-standing practice of producing an iatrogenic left bundle branch block by conventional RV pacing in patients receiving standard permanent pacemakers; the question of precisely where on the left ventricle optimal pacing is achieved; and the potential applications of CRT in patients with pediatric or congenital heart disease. Considering how major advances have been achieved since the first clinical application of CRT in 1994, one can be optimistic about the future of the electrotherapeutic management of heart failure.

UR - http://www.scopus.com/inward/record.url?scp=23944474034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944474034&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2005.04.050

DO - 10.1016/j.amjcard.2005.04.050

M3 - Article

C2 - 16125501

AN - SCOPUS:23944474034

VL - 96

SP - 710

EP - 717

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 5

ER -